Introducing the paths taken by Megen’s R&D Center.
Megen will strive to make a happier future by growing its dreams.

• Research Activities

  • Development of next-generation implant (2020–2023)
    • Prior technologies Research
    • Embodied development concept and directions
    • Ensured performance, reliability and stability of prosthetics
    • Acquired GMP certificate and clinical trial
    • Constructed mass production facilities and acquisition of manufacturing license
  • Development of transdermal drug (2021 2H–2024)
    • Researched patent map (biopolymer)
    • Feasibility Study

• Performance (Patents/Dissertations/National Tasks)

  • Patent Applications/Registrations
    • Next-generation implant: Completion of domestic patent registration (January 28, 22)
    • Next-generation implant: Completed PCT application (PCT/KR2021/009985)
    • Next-generation implant: Completed application in the U.S. and China (September 2021)
  • National Tasks: In application
  • University–Industry Collaborations
    • Signed a strategic business agreement (MOU) with TMD Lab